Instructions to Authors  by unknown
1. Manuscript Submission
Manuscripts (meaning all submission items, including all 
text, tables, artwork, cover letter, conflicts of interest 
disclosures, and any other required documents/material) 
may be submitted online at www.surgery.org.tw/SURGERY/
Default.aspx or by e-mail to journal@24drs.com. If assistance 
is needed, the Editorial Office can be contacted. Please do 
not post or fax your manuscripts to the Editorial Office.
Editorial Office
Formosan Journal of Surgery 
3F., No. 31, Section 5, Nanjing East Road, Taipei 105, Taiwan
Tel: (+886) 2-27697845 ext 15
Fax: (+886) 2-27467149
E-mail: journal@24drs.com
1.1. Important Information
•   Articles should be in Microsoft Word document format and 
prepared in the simplest form possible. We will add in the 
correct font, font size, margins and so on according to 
the Journal’s style.
•   You may use automatic page numbering, but do NOT use 
other kinds of automatic formatting such as footnotes, end-
notes, headers and footers. References especially should 
NOT be formatted using the MS Word “endnotes” or “foot-
notes” function; instead, you may use the commercially 
available EndNote® or Reference Manager® software to 
manage your references.
•   Put text, references, table headings and tables, and fig-
ure legends in one file.
•   Figures must be submitted as separate picture files, at 
the correct resolution and named according to the figure 
number and format, e.g., “Fig1.tif”, “Fig2.jpg”. Please 
see section 9.8. for more information.
1.2. Supporting Documents
The following documents must be included in your 
submission (refer also to the Checklist that follows these 
author instructions). Items (1), (2) and (3) are mandatory. 
Items (4), (5), (6) and (7) are required only if they are 
applicable to your manuscript.
(1) Cover Letter. This must include the following information:
•   title of the manuscript
•   names (spelled out in full) of all the authors*, and the in-
stitutions with which they are affiliated; indicate all af-
filiations with a superscripted lowercase letter after the 
 author’s name and in front of the matching affiliation (*the 
name of each author should be written with the family 
name last, e.g., Wan-Lin Chang)
•   corresponding author details (name, e-mail, mailing ad-
dress, telephone and fax numbers)
•   a statement that the material contained in the manuscript 
has not been previously published and is not being concur-
rently submitted elsewhere
•   persons who do not fulfill the requirements to be listed 
as authors but who nevertheless contributed to the manu-
script (such as those who provided writing assistance, for 
example) should be disclosed
•   list of manuscripts that have been published, submitted, or 
are in press that are similar to the submission to the FJS (and 
include in your submission copies of those similar manu-
scripts so that FJS Editors can be assured there is no overlap)
•   the signature of the corresponding author
Optional: if you have a list of reviewers who you wish to re-
view or not to review your manuscript, you may include this 
list in the cover letter
(2) Authorship & Conflicts of Interest Statement. Each au-
thor’s contribution to the manuscript should be listed. Any 
and all potential and actual conflicts of interest should also 
be listed (see Section 2 for more information). Please use 
the FJS Authorship & Conflicts of Interest Statement form 
that follows these author instructions and that is also pro-
vided on the Journal’s website at www.e-fjs.com. Your sig-
nature and those of ALL your coauthors must be included.
(3) Copyright Transfer Agreement. In the event that your 
manuscript is accepted for publication in the FJS, you are 
required to transfer all copyright ownership in and relat-
ing to the work to the Taiwan Surgical Association. Please 
use the FJS Copyright Transfer Agreement form that fol-
lows these author instructions and that is also provided on 
the Journal’s website at www.e-fjs.com. Your signature and 
those of ALL your coauthors must be included.
(4) Ethics Statement. Articles covering the use of human 
or animal samples in research, or human or animal experi-
ments must be accompanied by a letter of approval from 
the relevant review committee or authorities. See Section 3 
for more information.
(5) Consolidated Standards of Reporting Trials (CONSORT) 
flow chart for randomized controlled trials submitted for 
publication. See Section 4 for more information.
INSTRUCTIONS TO AUTHORS
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(6) Signed Statement of Informed Consent. Articles where 
human subjects can be identified in descriptions, photographs 
or pedigrees must be accompanied by a signed statement 
of informed consent to publish (in print and online) the 
descriptions, photographs and pedigrees from each subject 
who can be identified. See Section 5 for more information.
(7) Copyright Permission. If you have reproduced or adapted 
material from other copyrighted sources, the letter(s) of 
permission from the copyright holder(s) to reproduce or 
adapt the copyrighted sources must be supplied. Otherwise, 
such material must be removed from your manuscript.
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s objectivity 
is potentially compromised by a desire for financial gain, 
prominence, professional advancement or a successful out-
come. FJS Editors strive to ensure that what is published in 
the Journal is as balanced, objective and evidence-based 
as possible. Since it can be difficult to distinguish between 
an actual conflict of interest and a perceived conflict of in-
terest, the Journal requires authors to disclose all and any 
potential conflicts of interest.
Conflicts of interest may be financial or non-financial. 
Financial conflicts include financial relationships such as 
honoraria; educational grants; participation in speakers’ 
bureaus; membership, employment, consultancies, stock 
ownership, or other equity interest; expert testimony or 
patent-licensing arrangements. Non-financial conflicts in-
clude personal or professional relationships, affiliations, 
academic competition, intellectual passion, knowledge or 
beliefs that might affect objectivity.
Please ensure that the name of each author listed in your 
manuscript appears in either Section I or Section II on page 
2 of the FJS Authorship & Conflicts of Interest Statement 
form (an author’s name cannot appear in both Section I and 
Section II of the form).
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, appropriate 
institutional review board or ethics committee approval 
is required, and such approval should be stated in the 
methods section of the manuscript. For those investigators 
who do not have formal ethics review committees, the 
principles outlined in the Declaration of Helsinki should 
be followed (World Medical Association. Declaration of 
Helsinki: ethical principles for medical research involving 
human subjects. Available at: http://www.wma.net/
en/30publications/10policies/b3/index.html).
For investigation of human subjects, state explicitly 
in the methods section of the manuscript that informed 
consent was obtained from all participating adult 
subjects and from parents or legal guardians for minors or 
incapacitated adults, together with the manner in which 
informed consent was obtained (i.e., oral or written). 
For work involving animals, the guidelines for their care 
and use that were followed should be stated in the methods 
section of the manuscript. For those investigators who do 
not have formal institutional guidelines relating to animal 
experiments, the European Commission Directive 86/609/
EEC for animal experiments (available at http://ec.europa.
eu/environment/chemicals/lab_animals/legislation_
en.htm) should be followed and the same should be stated 
in the methods section of the manuscript.
4. Reporting Clinical Trials
All randomized controlled trials submitted for publication 
should include a completed Consolidated Standards of 
Reporting Trials (CONSORT) flow chart (please go to www.
consort-statement.org for more information). The FJS has 
adopted the ICMJE proposal that requires, as a condition of 
consideration for publication of clinical trials, registration in a 
public trials registry. Trials must register at or before the onset 
of patient enrolment. The clinical trial registration number 
should be included at the end of the abstract of the article.
For this purpose, a clinical trial is defined as any research 
study that prospectively assigns human participants or groups 
of humans to one or more health-related interventions to 
evaluate the effects of health outcomes. Health-related 
interventions include any intervention used to modify a 
biomedical or health-related outcome (for example drugs, 
surgical procedures, devices, behavioral treatments, dietary 
interventions, and process-of-care changes). Health outcomes 
include any biomedical or health-related measures obtained in 
patients or participants, including pharmacokinetic measures 
and adverse events.
Purely observational studies (those in which the assignment 
of the medical intervention is not at the discretion of the 
investigator) will not require registration. Further information 
can be found at www.icmje.org.
5.  Identification of Patients in Descriptions, Photographs 
and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all persons (parents or 
legal guardians for minors) who can be identified (including 
by the patients themselves) in such written descriptions, 
photographs or pedigrees. Such persons should be shown the 
manuscript before its submission. Omitting data or making 
data less specific to de-identify patients is acceptable, but 
changing any such data is not acceptable. 
State explicitly in the methods section of the manuscript 
that informed consent was obtained from all participating 
adult subjects or from parents or legal guardians for minors 
or incapacitated adults, together with the manner in which 
informed consent was obtained (i.e., oral or written).
6.  Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the 
understanding that they have not been published previously 
in print or electronic format (except in abstract or poster 
form) and are not under consideration in totality or in part 
by another publication or electronic medium.
7.  Basic Criteria
Articles should be written in English (using American English 
spelling) and meet the following basic criteria: the material 
is original, the information is important, the writing is clear 
and concise, the study methods are appropriate, the data 
are valid, and the conclusions are reasonable and supported 
by the data.
8. Categories of Articles
The article categories that are published in the Journal are 
listed and described below. Please select the category that 
best describes your paper. If your paper does not fall into 
any of these categories, please contact the Editorial Office.
8.1. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical subject in the field, and 
should be systematic and critical assessments of literature 
and data sources. They should cover aspects of a topic in 
which scientific consensus exists as well as aspects that 
remain controversial and are the subject of ongoing scientific 
research. All articles and data sources reviewed should include 
information about the specific type of study or analysis, 
population, intervention, exposure, and tests or outcomes. All 
articles or data sources should be selected systematically for 
inclusion in the review and critically evaluated. By invitation 
only. The format for review articles will be jointly decided by 
the Editors and the contributing author.
Format guide
•   Word limit: 4500 words (excluding abstract and references)
•   References: 50 or less
•   Abstract: up to 250 words, unstructured (i.e., no 
subheadings)
•   Keywords: 3—5 
•   Tables/Figures: no limit, but data in text should not be 
repeated extensively in tables or figures
8.2. Original Articles
These articles typically include randomized trials, inter-
vention studies, studies of screening and diagnostic tests, 
laboratory and animal studies, cohort studies, cost-effec-
tiveness analyses, case-control studies, and surveys with 
high response rates, which represent new and significant 
contributions to the field.
Section headings should be: Abstract, Introduction, 
Methods, Results, Discussion, Acknowledgments (if any), 
and References.
The Introduction should provide a brief background to 
the subject of the paper, explain the importance of the 
study, and state a precise study question or purpose.
The Methods section should describe the study design 
and methods (including the study setting and dates, pa-
tients/participants with inclusion and exclusion criteria, 
patient samples or animal specimens used, the essential 
features of any interventions, the main outcome measures, 
the laboratory methods followed, or data sources and how 
these were selected for the study), and state the statistical 
procedures employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat data 
that are presented in tables and/or figures. Only emphasize 
and summarize the essential features of the main results.
The Discussion section should be used to emphasize the 
new and important aspects of the study, placing the results in 
context with published literature, the implications of the find-
ings, and the conclusions that follow from the study results.
Format guide
•   Word limit: 3500 words (excluding abstract and refer-
ences)
•   References: 30 or less
•   Abstract: up to 250 words, structured (i.e., with 
the section headings Background/Introduction, 
Purpose(s)/Aim(s), Methods, Results and Conclusion)
•   Keywords: 3—5 
•   Tables/Figures: no limit, but data in text should not be 
repeated extensively in tables or figures.
8.3. Mini-review Articles
A mini-review article is a critical assessment and short re-
view of an issue in research or clinical practice. Systematic 
methods for inclusion of all data sources and critical review 
of those sources should be described in the paper. There is 
no fixed format for mini-review articles. However, only a 
single author is allowed, and the author should have pub-
lished in a SCI-indexed journal. 
Format guide
•   Word limit: 2000 words (excluding abstract and refer-
ences)
•   References: 30 or less
•   Abstract: up to 250 words, unstructured (i.e., no sub-
headings)
•   Keywords: 3—5 
•   Tables/Figures: 1 table and/or 1 figure
8.4. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make an im-
portant teaching point or scientific observation. They may 
describe novel techniques or use of equipment, or new 
information on diseases of importance. Section headings 
should be: Abstract, Introduction, Case Report, Discussion, 
Acknowledgments (if any), and References.
The Introduction should describe the purpose of the 
present report, the significance of the disease and its spe-
cificity, and briefly review the relevant literature.
The Case Report should include the general data of 
the case, medical history, family history, chief complaint, 
present illness, clinical manifestation, methods of diagnosis 
and treatment, and outcome.
The Discussion should compare, analyze and discuss the 
similarities and differences between the reported case and 
similar cases reported in other published articles. The im-
portance or specificity of the case should be restated when 
discussing the differential diagnoses. Suggest the prognosis 
of the disease and possibility of prevention.
Format guide
•   Authors: no more than 6
•   Word limit: 2000 words (excluding abstract and references)
•   References: 10 or less
•   Abstract: up to 250 words, unstructured (i.e., no sub-
headings)
•   Keywords: 3—5 
•   Tables/Figures: no limit, but data in text should not be 
repeated extensively in tables or figures
8.5. Surgeon at Work
These articles should provide unique information about an 
operation or procedure that has an impact on the clinical 
practice of surgeons, or a “how to do it”. 
Format guide
• Word limit: 1200 words (excluding references)
• References: 5 or less
• Abstract: none
• Keywords: none
• Tables: no more than 1
• Figures: no limit
8.6. Images for Surgeons
These may include X-rays, pathology photographs, im-
ages taken in the operating room, or other relevant clini-
cal pictures of unusual findings of surgical diseases, typical 
features of uncommon diseases, and rare presentations or 
findings of common surgical problems. Images with relevant 
history, clinical and laboratory findings, details of (any) sur-
gical intervention and outcomes should be presented. De-
scriptions of the images must be included in the text. All 
information that could identify patients in the images must 
be removed before they are submitted. 
Format guide
• Word limit: 500 words (excluding references)
• References: 5 or less
• Abstract: none
• Keywords: none
• Tables: no more than 1
• Figures: no limit
8.7. Meeting Reports
These are reports and comments on recent surgical 
meetings and should explain the importance of the surgical 
meetings.
Format guide
• Word limit: 1000 words (excluding references)
• References: 5 or less
• Abstract: none
• Keywords: none
• Tables: no more than 1
• Figures: none
8.8. Short Communications
These reports should be concise presentations of clinical or 
preliminary experimental results. The Editors reserve the 
right to decide what constitutes a Short Communication.
Format guide
•  Word limit: 1200 words (excluding abstract and refer-
ences)
• References: 10 or less
•  Abstract: up to 250 words, unstructured (i.e., no subhead-
ings)
• Keywords: 3—5 
• Tables/Figures: up to 4 tables/figures
8.9. Letters to the Editor
Letters are welcome in response to previously published FJS 
articles, and may also include interesting cases that do not 
meet the requirement of being truly exceptional, and other 
communications of general interest. Letters should have a 
title and include the author’s mailing and e-mail addresses. 
Letters are edited, sometimes extensively, to sharpen their 
focus. They may be sent for peer review at the discretion 
of the Editors. Letters are selected based on clarity, signifi-
cance, and space.
Format guide
• Word limit: 500 words (excluding references)
• References: 5 or less
• Abstract: none
• Keywords: none
• Tables/Figures: 1 table and/or 1 figure
• Begin with “Dear Editor”
• No subheadings
8.10 Correspondence 
These include short case reports, technical or clinical notes 
and short comments on previously published FJS articles. 
The Editors reserve the right to decide what constitutes a 
Correspondence.
Format guide
• Authors: no more than 4
• Word limit: 500 words (excluding references)
• References: 5 or less
• Abstract: none
• Keywords: none
• Tables/Figures: 1 table or 1 figure
• No subheadings
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297 × 210 
mm) paper, with outer margins of 2.5 cm. The manuscript 
should include a title page, abstract, keywords, main text, 
acknowledgments (if any), references, and figures and ta-
bles as appropriate. Each section of the manuscript should 
begin on a new page. Pages should be numbered consecu-
tively, beginning with the title page.
9.1. Title Page
The title page should contain the following information (in 
order, from the top to bottom of the page):
• article category
• article title
•  declaration of any potential financial and non-financial 
conflicts of interest
•  running title not exceeding 50 characters
IMPORTANT: please do NOT include any author names and 
affiliations or corresponding author information on the title 
page (this information should be listed in your cover letter 
instead) because the FJS follows a double-blind peer review 
process.
9.2. Abstract and Keywords
A concise and factual abstract of no more than 250 words in 
length, and 3—6 relevant keywords (in alphabetical order) 
are required for the following article categories: Review Ar-
ticles, Original Articles, Mini-review Articles, Case Reports, 
and Short Communications.
Abstracts for Original Articles should be structured, 
with the section headings: Background/Introduction, 
Purpose(s)/Aim(s), Methods, Results and Conclusion. 
Abstracts for Review Articles, Mini-review Articles, Case Re-
ports and Short Communications should be unstructured, in 
one single paragraph with no section headings.
The abstract should state briefly the purpose of the re-
search, the principal results and major conclusions. For 
Case Reports, the abstract should include the significance 
and purpose of the case presentation, the diagnostic meth-
ods of the case, the key data, and brief comments and sug-
gestions with regard to the case.
An abstract is often presented separately from the ar-
ticle, so it must be able to stand alone. For this reason, 
References should be avoided, but if essential, then cite 
the author(s) and year(s). Also, non-standard or uncom-
mon abbreviations should be avoided, but if essential 
they must be defined at their first mention in the abstract 
itself.
Keywords will be used for indexing purposes and should 
be taken from the Medical Subject Headings (MeSH) list of 
Index Medicus (www.nlm.nih.gov/mesh/meshhome.html). 
Avoid general and plural terms and multiple concepts 
(avoid, for example, “and”, “of”). Be sparing with abbre-
viations: only abbreviations firmly established in the field 
may be eligible.
No abstract or keywords are required for Surgeon at 
Work, Images for Surgeons, Meeting Reports, Letters to the 
Editor, and Correspondence.
9.3. Main Text
The text for Original Articles should be organized into the 
following sections: Background/Introduction, Purpose(s)/
Aim(s), Methods, Results, Discussion, Acknowledgments 
(if any), and References. Sections for Case Reports are: 
Introduction, Case Report, Discussion, Acknowledgments 
(if any), and References. Each section should begin on a 
new page.
9.3.1. Abbreviations
Where a term/definition will be continually referred to, it 
must be written in full when it first appears in the text, 
followed by the subsequent abbreviation in parentheses. 
Thereafter, the abbreviation may be used. 
An abbreviation should not be first defined in any section 
heading; if an abbreviation has previously been defined in 
the text, then the abbreviation may be used in a subsequent 
section heading. Restrict the number of abbreviations to 
those that are absolutely necessary and ensure consistency 
of abbreviations throughout the article.
9.3.2. Numbers
Numbers that begin a sentence or those that are less than 10 
should be spelled out using letters. Centuries and decades 
should be spelled out, e.g., the Eighties or nineteenth cen-
tury. Laboratory parameters, time, temperature, length, 
area, mass, and volume should be expressed using digits.
9.3.3. Units
Système International (SI) units must be used, with the ex-
ception of blood pressure values which are to be reported 
in mmHg. Please use the metric system for the expression 
of length, area, mass, and volume. Temperatures are to be 
given in degrees Celsius.
9.3.4. Names of Drugs, Devices and Other Products
Use the Recommended International Non-proprietary 
Name (rINN) for medicinal substances, unless the specific 
trade name of a drug is directly relevant to the discussion. 
Generic drug names should appear in lowercase letters 
in the text. If a specific proprietary drug needs to be 
identified, the brand name may appear only once in the 
manuscript in parentheses following the generic name the 
first time the drug is mentioned in the text.
For devices and other products, the specific brand or 
trade name, the manufacturer and their location (city, 
state, country) should be provided the first time the 
device or product is mentioned in the text, for example, 
“…IBM SPSS Statistics 21.0 was used (IBM Corp., Armonk, 
NY, USA)”. Thereafter, the generic term (if appropriate) 
should be used.
9.3.5. Gene Nomenclature
Current standard international nomenclature for genes 
should be adhered to. For human genes, use genetic notation 
and symbols approved by the HUGO Gene Nomenclature 
Committee (www.genenames.org). You may also refer to 
the resources available on PubMed at www.ncbi.nlm.nih.
gov/guide/genes-expression. The Human Genome Variation 
Society has a useful site that provides guidance in naming 
mutations at www.hgvs.org/mutnomen/index.html. In 
your manuscript, genes should be typed in italic font and 
include the accession number.
9.3.6. Statistical Requirements
Statistical analysis is essential for all research papers 
except case reports. Use correct nomenclature for sta-
tistical methods (e.g., two sample t test, not unpaired 
t test). Descriptive statistics should follow the scales 
used in data description. Inferential statistics are impor-
tant for interpreting results and should be described in 
detail.
All p values should be presented to the third decimal place 
for accuracy. The smallest p value that should be expressed 
is p < 0.001 since additional zeros do not convey useful 
information; the largest p value that should be expressed 
is p > 0.99.
9.3.7. Personal Communications and Unpublished Data
These sources cannot be included in the references list but 
may be described in the text. The author(s) must give the 
full name and highest academic degree of the person, the 
date of the communication, and indicate whether it was 
in oral or written (letter, fax, e-mail) form. A signed state-
ment of permission should be included from each person 
identified as a source of information in a personal commu-
nication or as a source for unpublished data.
9.4. Funding/Support Statement
All financial and material support for the research, work, 
writing and editorial assistance from internal or external 
agencies, including commercial companies, should be clearly 
and completely identified in a Funding/Support Statement.
9.5. Acknowledgments
General acknowledgments for consultations and statis-
tical analyses should be listed concisely, including the 
names of the individuals who were directly involved. 
Consent should be obtained from those individuals before 
their names are listed in this section. Those acknowl-
edged should not include secretarial, clerical or techni-
cal staff whose participation was limited to the perform-
ance of their normal duties.
9.6. References 
Authors are responsible for the accuracy and completeness 
of their references and for correct in-text citation.
9.6.1. In the Main Text, Tables and Figure Legends
•  References should be identified using superscripted num-
bers, and numbered consecutively in order of appearance 
in the text; the numbers should be placed after periods 
and commas and before colons and semicolons.
•  References cited in tables or figure legends should be in-
cluded in sequence at the point where the table or figure 
is first mentioned in the main text.
•  Do not cite abstracts unless they are the only available 
reference to an important concept.
•  Do not cite uncompleted work or work that has not yet 
been accepted for publication (i.e., “unpublished obser-
vation”, “personal communication”) as references. Also 
see Section 9.3.7.
9.6.2. In the References List
•  References should be compiled at the end of the manu-
script according to the order of citation in the text.
•  References should be limited to those cited in the text 
only.
•  Journal references should include, in order, authors’ 
surnames and initials, article title, abbreviated journal 
name, year, volume and inclusive page numbers.
•  The surnames and initials of all the authors up to 6 should 
be included, but when authors number 7 or more, list the 
first 3 authors only followed by “et al”.
•  Abbreviations for journal names should conform to those 
used in MEDLINE.
•  If citing a website, provide the author information, arti-
cle title, website address and the date you accessed the 
information.
•  Reference to an article that is in press must state the 
journal name and, if possible, the year and volume.
Examples of the most common reference types are provided 
below. (Please pay particular attention to the formatting, 
word capitalization, spacing and style.)
Standard journal articles
Bisdas T, Pichlmaier M, Wilhelmi M, Bisdas S, Haverich A, 
Teebken O. Effects of the ABO-mismatch between donor 
and recipient of cryopreserved arterial homografts. Int An-
giol. 2011;30:247—255.
Quintini C, D’Amico G, Brown C, et al. Splenic artery em-
bolization for the treatment of refractory ascites after liver 
transplantation. Liver Transpl. 2011;17:668—673.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and 
therapeutic target: what criteria should we apply? J 
Cardiovasc Pharmacol. 1998;32(suppl 3):S78—80.
Journal article not in English but with English abstract
Kawai H, Ishikawa T, Moroi J, et al. Elderly patient with 
cerebellar malignant astrocytoma. No Shinkei Geka. 
2008;36:799–805. [In Japanese, English abstract]
Book
Bradley EL. Medical and Surgical Management. Philadel-
phia: Saunders; 1982:72—95.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: Under-
wood JCE, ed. General and Systematic Pathology. 4th ed. 
London: Churchill Livingstone; 2004:615—672.
Bulletin
World Health Organization. World Health Report 2002: Re-
ducing Risk, Promoting Healthy Life. Geneva, Switzerland: 
World Health Organization; 2002.
Conference proceedings
Pacak K, Aguilera G, Sabban E, Kvetnansky R, eds. Stress: 
Current Neuroendocrine and Genetic Approaches. 8th Sym-
posium on Catecholamines and Other Neurotransmitters in 
Stress, June 28—July 3, 2003, Smolenice Castle, Slovakia. 
New York: New York Academy of Sciences; 2004.
Thesis
Ayers AJ. Retention of Resin Restorations by Means of 
Enamel Etching and by Pins [MSD thesis]. Indianapolis: 
Indiana University; 1971.
Website
Wisdom Teeth. American Association of Oral and Maxillofacial 
Surgeons Web site. http://www.aaoms.org/wisdom_teeth.
php. Accessed November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. Cat-
alog No. 49. Rochester, NY: Eastman Kodak; 1977:2—3.
9.7. Tables
Tables should supplement, not duplicate, the text. They 
should have a concise table heading, be self-explanatory, 
and numbered consecutively in the order of their citation 
in the text. Items requiring explanatory footnotes should 
be denoted using superscripted lowercase letters (a, b, c, 
etc.), with the footnotes arranged under the table in alpha-
betical order. Asterisks (*, **) are used only to indicate the 
probability level of tests of significance. Abbreviations used 
in the table must be defined and placed after the footnotes 
in alphabetical order. If you include a block of data or ta-
ble from another source, whether published or unpublished, 
you must acknowledge the original source.
9.8. Figures
9.8.1. General Guidelines
The number of figures should be restricted to the mini-
mum necessary to support the textual material. Figures 
should have an informative figure legend and be numbered 
in the order of their citation in the text. All symbols and 
abbreviations should be defined in the figure legend in al-
phabetical order. Items requiring explanatory footnotes 
should follow the same style as that for tables as described 
in Section 9.7.
Unless you have written permission from the patient (or, 
where applicable, the next of kin), the personal details 
(such as their name and date of birth) of the patient must 
be removed. If their face is shown, use a black bar to cover 
their eyes so that they cannot be identified (for further in-
formation, see www.elsevier.com/patientphotographs).
All lettering should be done professionally and should be 
in proportion to the drawing, graph or photograph. Phot-
omicrographs must include an internal scale marker, and 
the legend should state the type of specimen, original mag-
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Figures must be submitted as separate picture files, at the 
correct resolution (see Section 9.8.2.) and named according 
to the figure number and format, e.g., “Fig1.tif”, “Fig2.jpg”.
9.8.2. Formats
Regardless of the application used, when your electronic 
artwork is finalized, please “save as” or convert the im-
ages to one of the following formats (note the resolution re-
quirements for line drawings, halftones, and line/halftone 
combinations given below):
•  EPS: vector drawings. Embed the font or save the text as 
“graphics”.
•  TIFF: color or grayscale photographs (halftones)—use a 
minimum of 300 dpi.
•  TIFF: bitmapped line drawings—use a minimum of 1000 
dpi.
•  TIFF: combination of bitmapped line/halftone (color or 
grayscale)—use a minimum of 600 dpi.
•  DOC, XLS or PPT: if your electronic artwork is created in 
any of these Microsoft Office applications, please supply 
“as is”.
Please do not:
•  Supply files that do not meet the resolution requirements 
detailed above;
•  Supply files that are optimized for screen use (such as GIF, 
BMP, PICT, WPG) as the resolution is too low;
•  Submit graphics that are disproportionately large for the 
content.
A detailed guide on electronic artwork is available at www.
elsevier.com/artworkinstructions. Please note that the 
cost of color illustrations will be charged to the author 
(see Section 12 for more information).
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